American Journal of Clinical Dermatology

Papers
(The TQCC of American Journal of Clinical Dermatology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review280
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women’s Health Initiative187
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments125
Prognostic Biomarkers in Evolving Melanoma Immunotherapy104
Role of Inflammation and Cytokine Dysregulation in Depression in Patients with Inflammatory Skin Conditions103
The Current State of Systemic Therapy of Metastatic Uveal Melanoma94
Disease Duration in Patients Recruited to Psoriasis Phase III Trials: A Systematic Review87
The Burden of Pediatric Psoriasis: A Systematic Review77
Predicting the Time to Relapse Following Withdrawal from Different Biologics in Patients with Psoriasis who Responded to Therapy: A 12-Year Multicenter Cohort Study75
Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell Carcinoma74
Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study73
Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials70
Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments70
Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know70
Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data65
Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review65
Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology64
Agreement Between Nail Psoriasis Severity Index Scores by a Convolutional Neural Network and Dermatologists: A Retrospective Study at an Academic New York City Institution64
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroi61
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks59
Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?57
Comment on: “Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?”54
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation53
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion53
Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study51
Skin Cancer in Solid Organ Transplant Recipients: A Review50
Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry49
Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment49
Disease Modification in Psoriasis: Future Prospects for Long-Term Remission48
48-Week Real-World Outcomes of Lebrikizumab Treatment for Atopic Dermatitis: Systemic Therapy-Naive Versus -Experienced Patients48
Ethnic Differences of Palmoplantar Pustulosis: A Systematic Review47
Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management46
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives46
Dissecting Cellulitis of the Scalp: Current Insights and Therapeutic Advances44
Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!43
A Practice Approach to Acne Fulminans in Adolescents43
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis41
Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment41
Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis39
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment Hist38
Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review37
Exposome Risk Factors for Vitiligo: A Systematic Evidence Review37
Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa37
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates35
Scratching the Surface: A Comprehensive Guide to Understanding and Managing Vulvovaginal Itching34
The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases33
Oral Lichen Planus: An Update on Diagnosis and Management32
A Review of the Etiologies and Key Clinical Features of Secondary Hyperhidrosis32
Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm31
Commentary on “Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology”30
The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes?30
The Burden of Acne Vulgaris on Health-Related Quality of Life and Psychosocial Well-Being Domains: A Systematic Review29
Frontal Fibrosing Alopecia: An Update29
Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists28
Individualized Neoantigen-Directed Melanoma Therapy28
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada28
Expert Recommendations for the Diagnosis and Management of Chronic Hand Eczema in the United States28
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)27
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History27
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study27
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials26
Advancing Precision Medicine in Inflammatory Skin Disease26
JAK Inhibitors and Inflammatory Nail Disorders: A Systematic Review of Clinical Outcomes and Therapeutic Potential26
Targeting Inflammation in Acne: Current Treatments and Future Prospects25
Autoimmune and Cutaneous Inflammatory Comorbidities in Adult-Onset Morphea in the All of Us Research Program25
Acknowledgement to Referees24
Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study24
Comment on: “Eyebrow and Eyelash Alopecia: A Clinical Review”24
Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review24
Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 Patients23
Acknowledgement to Referees23
Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis22
Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea21
Cutaneous Small Vessel Vasculitis: A Practical Guide to Diagnosis and Management21
Approach to the Atypical Wound21
Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial Results21
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion 21
Management of Acne in Pregnancy21
Exploring Suzetrigine's Role in Dermatologic Surgery: A Novel Nonopioid Analgesic for Postoperative Pain Management20
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study20
Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year20
Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt Treatment20
The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights19
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-219
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations19
Treatment Strategies for Chronic Pruritus and Eczema/Dermatitis in Older Adults Under the Category of Chronic Eczematous Eruptions of Aging (CEEA)18
Review of Laser Treatments for Post-Inflammatory Hyperpigmentation in Skin of Color18
0.1768000125885